Vitrolife AB (publ) (LON:0YAY)
141.70
+2.14 (1.53%)
At close: Dec 5, 2025
Vitrolife AB Revenue
Vitrolife AB had revenue of 835.00M SEK in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 3.51B, down -1.35% year-over-year. In the year 2024, Vitrolife AB had annual revenue of 3.61B with 2.76% growth.
Revenue (ttm)
3.51B SEK
Revenue Growth
-1.35%
P/S Ratio
5.51
Revenue / Employee
3.00M SEK
Employees
1,169
Market Cap
1.52B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |